ArticleInvestigational new drugs2014

Investigational Aurora A kinase inhibitor alisertib (MLN8237) as an enteric-coated tablet formulation in non-hematologic malignancies: phase 1 dose-escalation study.

Gerald Falchook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.